Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma
Authors
Keywords
-
Journal
Nature Communications
Volume 8, Issue -, Pages -
Publisher
Springer Nature
Online
2017-02-15
DOI
10.1038/ncomms14278
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
- (2016) Eric Bouffet et al. JOURNAL OF CLINICAL ONCOLOGY
- BIRC3 is a novel driver of therapeutic resistance in Glioblastoma
- (2016) Dapeng Wang et al. Scientific Reports
- Anti-programmed cell death protein-1/ligand-1 therapy in different cancers
- (2015) B Homet Moreno et al. BRITISH JOURNAL OF CANCER
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- Combinatorial cancer immunotherapy strategies with proapoptotic small-molecule IAP antagonists
- (2015) Shawn T. Beug et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Evolving treatment options for melanoma brain metastases
- (2015) Thankamma Ajithkumar et al. LANCET ONCOLOGY
- The diverse role of RIP kinases in necroptosis and inflammation
- (2015) John Silke et al. NATURE IMMUNOLOGY
- Prospects of immune checkpoint modulators in the treatment of glioblastoma
- (2015) Matthias Preusser et al. Nature Reviews Neurology
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
- (2015) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Robust Antitumor Effects of Combined Anti-CD4-Depleting Antibody and Anti-PD-1/PD-L1 Immune Checkpoint Antibody Treatment in Mice
- (2015) S. Ueha et al. Cancer Immunology Research
- Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model
- (2015) D. A. Reardon et al. Cancer Immunology Research
- Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors
- (2014) D. A. Wainwright et al. CLINICAL CANCER RESEARCH
- Birinapant, a Smac-Mimetic with Improved Tolerability for the Treatment of Solid Tumors and Hematological Malignancies
- (2014) Stephen M. Condon et al. JOURNAL OF MEDICINAL CHEMISTRY
- Long-Distance Interferon Signaling within the Brain Blocks Virus Spread
- (2014) A. N. van den Pol et al. JOURNAL OF VIROLOGY
- Smac mimetics and innate immune stimuli synergize to promote tumor death
- (2014) Shawn T Beug et al. NATURE BIOTECHNOLOGY
- Ubiquitination in disease pathogenesis and treatment
- (2014) Doris Popovic et al. NATURE MEDICINE
- Th17 Cells in Cancer: The Ultimate Identity Crisis
- (2014) Stefanie R. Bailey et al. Frontiers in Immunology
- Inflammation Amplifier, a New Paradigm in Cancer Biology
- (2013) T. Atsumi et al. CANCER RESEARCH
- Second mitochondria-derived activator of caspase (SMAC) mimetic potentiates tumor susceptibility toward natural killer cell-mediated killing
- (2013) Kerstin Brinkmann et al. LEUKEMIA & LYMPHOMA
- Resistance to Oncolytic Myxoma Virus Therapy in Nf1−/−/Trp53−/− Syngeneic Mouse Glioma Models Is Independent of Anti-Viral Type-I Interferon
- (2013) Franz J. Zemp et al. PLoS One
- Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity
- (2013) D Lecis et al. Cell Death & Disease
- Model-based rational design of an oncolytic virus with improved therapeutic potential
- (2013) Fabrice Le Bœuf et al. Nature Communications
- Non-replicating rhabdovirus-derived particles (NRRPs) eradicate acute leukemia by direct cytolysis and induction of antitumor immunity
- (2013) C Batenchuk et al. Blood Cancer Journal
- Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy
- (2012) Ashley J. Knights et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks
- (2012) Michael J. Lee et al. CELL
- Balance between NF- B p100 and p52 Regulates T Cell Costimulation Dependence
- (2012) M. L. Giardino Torchia et al. JOURNAL OF IMMUNOLOGY
- Targeting IAP proteins for therapeutic intervention in cancer
- (2012) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Cellular Inhibitors of Apoptosis Are Global Regulators of NF- B and MAPK Activation by Members of the TNF Family of Receptors
- (2012) E. Varfolomeev et al. Science Signaling
- Modulation of immune signalling by inhibitors of apoptosis
- (2012) Shawn T. Beug et al. TRENDS IN IMMUNOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- An NF-κB p65-cIAP2 link is necessary for mediating resistance to TNF-α induced cell death in gliomas
- (2011) Xueyan Zhao et al. JOURNAL OF NEURO-ONCOLOGY
- The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPs
- (2011) Tencho Tenev et al. MOLECULAR CELL
- Initial testing (stage 1) of LCL161, a SMAC mimetic, by the pediatric preclinical testing program
- (2011) Peter J. Houghton et al. PEDIATRIC BLOOD & CANCER
- SMAC Mimetic BV6 Induces Cell Death in Monocytes and Maturation of Monocyte-Derived Dendritic Cells
- (2011) Nicole Müller-Sienerth et al. PLoS One
- Antagonists Induce a Conformational Change in cIAP1 That Promotes Autoubiquitination
- (2011) E. C. Dueber et al. SCIENCE
- IAP inhibitors enhance co-stimulation to promote tumor immunity
- (2010) Michael Dougan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production
- (2010) T. Alain et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Down-regulation of c-FLIP Enhances Death of Cancer Cells by Smac Mimetic Compound
- (2009) H. H. Cheung et al. CANCER RESEARCH
- Proliferation of Human Glioblastoma Stem Cells Occurs Independently of Exogenous Mitogens
- (2009) John J. P. Kelly et al. STEM CELLS
- Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK
- (2008) Brian J Zarnegar et al. NATURE IMMUNOLOGY
- Both cIAP1 and cIAP2 regulate TNF -mediated NF- B activation
- (2008) D. J. Mahoney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More